In 2019 a flavonoid of cannabis – Caflanone (FBL-03G) – was granted Orphan drug status by the United States Food and Drug Administration. Now, trials using the flavonoid to treat pancreatic cancer are anticipated to begin in the spring.

Flavocure, a drug discovery and development company, was granted Orphan drug status to its lead drug candidate, the cannabis flavonoid Caflanone (FBL-03G), by the United States Food and Drug Administration (FDA), following the successful demonstration of its therapeutic efficacy in tumour progression in animals with pancreatic cancer.

The company is now on track to begin clinical trials for treating pancreatic cancer with Caflanone in the spring. 

Click here to read the complete article

Health Europa

Recent News Articles

Monday March 02

Cannabis And Lou Gehrig’s Disease: Here’s What You Should Know - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

Considering the neuroprotective effects of cannabinoids and the anti-spastic effects of cannabinoids in multiple sclerosis…

1551 hits

Monday March 02

Bill To Legalize Marijuana Sales Officially Passes Vermont House Of Representatives - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

The Vermont House of Representatives finalized its approval of a bill to legalize the retail…

1480 hits

Monday March 02

Study reveals antibiotic potential of cannabis compound - Cannabis News

in Science

by Bruce Kennedy - Editor in Chief

A compound made by cannabis plants has been found to wipe out one of the…

1442 hits

Tuesday March 03

Utah’s first marijuana pharmacy opens in Salt Lake City - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

Utah’s first medical cannabis pharmacy opened Monday, giving patients a long-awaited legal option for buying…

1457 hits

Tuesday March 03

Cannabis and coronavirus: Here’s what you need to know - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

Given the general hype around CBD, expect to hear outlandish claims about its effect on…

1429 hits